To support its growth and innovative offerings, OHUS is also constructing a state-of-the-art facility in Gardena, California, scheduled for completion in Q2 2025. The Gardena facility will serve as a cornerstone of OHUS’s enhanced service capabilities and advanced diagnostics. Additionally, OHUS welcomes Ricky Kim as its new Chief Operating Officer. Ricky, a seasoned leader with over 22 years of experience in in-vitro diagnostics, healthcare IT, and strategic management, brings a wealth of knowledge from both Fortune 500 companies and startups.
Ricky Kim, newly appointed COO, expressed his enthusiasm for joining OHUS, stating, “OHUS is on a transformative journey, and I am honored to contribute to its U.S. expansion in providing affordable, accurate healthcare that’s accessible to patients around the world. With over two decades in healthcare and diagnostics, I look forward to supporting our mission through strategic growth and operational excellence that prioritize the highest standards in patient care.”
OHUS’s expansion marks a strategic investment in innovation and enhanced laboratory services for the U.S. market. With a comprehensive range of testing services, from routine to advanced molecular diagnostics, OHUS is pioneering a new era of health diagnostics to bring cutting-edge medical advancements from South Korea to the U.S. healthcare landscape.
